In 2005, for the first time, we reported that, in a population of advanced ovarian cancer assessed at diagnosis prior to any antineoplastic treatment, the severity of cancer-related anemia was associated with a status of chronic inflammation characterized by high levels of IL-6, CRP, and fibrinogen [28]. This evidence concerns the gene IL6 and ovarian carcinoma.